Prescriptions

The pharmacy regulator has advised that pharmacy teams carry out a “robust” assessment before supplying finasteride – a hair-loss drug with psychiatric and sexual health risks.

NICE has opened a consultation on the possible mass rollout of tirzepatide to millions of people in England over the next decade.

Novo Nordisk induced multiple “large” pharmacy chains to prescribe one of its weight loss drugs by providing “free of charge” sharps bins, needles and injection-pen travel wallets, the prescription medicine self-regulatory body has found.  

Healthcare professionals have been urged to stop supplying Oxbryta “immediately” after new data revealed “an unfavourable imbalance” of “fatal events” and “acute painful crises” in patients on the drug.  

The new government is “not in a position” to implement promised intercompany hub-and-spoke changes in January, the pharmacy negotiator has announced.

“Not following” the pharmacy regulator’s proposed new guidance on weight loss drugs and online pharmacy prescribing could result in fitness-to-practise (FtP) investigations into “all the pharmacy professionals involved”, it has warned.  

Amardip Virdi bought the “entire stock” of Ozempic at a pharmacy where he was working during a national shortage to supply it to private weight loss customers, the GPhC’s investigating committee has found.

Two Walgreens whistleblowers will receive multimillion-dollar rewards for alerting the US government to the pharmacy chain’s “false” prescription claims, the US justice department has revealed.

Derbyshire multiple Peak Pharmacy saw “difficult trading conditions” affect profitability despite rising sales, its annual report has revealed.

A Lloydspharmacy worker who stole Ozempic from the Widnes pharmacy she worked at has been given a suspended sentence of 29 weeks in prison.